XMTR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
XMTR is a good buy right now for a beginner long-term investor with $50,000-$100,000 available, and I would rate it as a Buy. The stock has strong bullish fundamental sentiment from analysts, a meaningful insider purchase, and supportive strategic catalyst news. While the technicals are not fully broken out yet, the price is holding above pivot support and the broader setup still looks constructive. Because the user wants a direct answer and is not waiting for a perfect entry, this is an acceptable entry now rather than a stock to avoid.
XMTR is in a short-term consolidation-to-uptrend phase. Current price is 88.015, above the pivot at 87.075 and below resistance at 95.876. RSI_6 at 61.783 is neutral-to-bullish and not overbought. MACD histogram is -1.823 but negatively contracting, which suggests bearish momentum is fading rather than accelerating. Moving averages are converging, indicating a potential trend inflection. Overall, the chart is constructive but not yet a breakout; still, current price action supports a buy on strength near current levels.
Recent positive catalysts include Xometry’s Q1 beat and raise, accelerating revenue for the third consecutive quarter, positive adjusted EBITDA for a sixth consecutive quarter, and the Siemens partnership, which analysts believe could significantly speed growth and profitability. Insider buying is also supportive: Director Lukas Biewald bought 47,058 shares for about $4 million at $85 each, which is a strong confidence signal. Analyst targets have moved materially higher across multiple firms, reinforcing the bullish catalyst stack.
The similar-pattern trend data also suggests downside over longer short-term horizons, with estimated weakness over the next week and month. Hedge funds and insiders are otherwise neutral outside the recent insider purchase, and there is no strong congress-trading signal to add support.
No detailed financial snapshot was available due to a data error, so I cannot assess exact latest-quarter margin or revenue figures. However, the analyst commentary indicates strong recent operating performance: revenue accelerated for the third straight quarter, adjusted EBITDA turned positive for the sixth consecutive quarter, and the full-year growth outlook improved. The latest quarter referenced is Q1 2026, and the overall trend points to improving growth and profitability.
Wall Street has turned meaningfully more constructive. Citi raised its target to $98 from $65 and kept Buy; RBC raised to $85 from $55 and kept Sector Perform; Goldman raised to $78 from $54 and kept Neutral; Citizens raised to $100 from $75 and kept Outperform; Cantor upgraded to Overweight from Neutral with a $62 target. The pros view is that marketplace growth is ramping, Siemens could accelerate scale, and profitability is improving. The cons view is that some firms still remain Neutral/Sector Perform, implying valuation and execution risk remain part of the debate, but the overall direction of ratings and targets is clearly upward.
